ATE209864T1 - Zusammensetzung zur behandlung von patienten mit lebererkrankungen - Google Patents

Zusammensetzung zur behandlung von patienten mit lebererkrankungen

Info

Publication number
ATE209864T1
ATE209864T1 AT94103163T AT94103163T ATE209864T1 AT E209864 T1 ATE209864 T1 AT E209864T1 AT 94103163 T AT94103163 T AT 94103163T AT 94103163 T AT94103163 T AT 94103163T AT E209864 T1 ATE209864 T1 AT E209864T1
Authority
AT
Austria
Prior art keywords
composition
patients
treatment
ready
liver diseases
Prior art date
Application number
AT94103163T
Other languages
English (en)
Inventor
Ahmad Reza Kamarei
Eric Leopold
Dirk H Montagne
Susan L Trimbo
Guy Vaussard
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Application granted granted Critical
Publication of ATE209864T1 publication Critical patent/ATE209864T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Pediatric Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
AT94103163T 1993-03-09 1994-03-03 Zusammensetzung zur behandlung von patienten mit lebererkrankungen ATE209864T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/028,373 US5571783A (en) 1993-03-09 1993-03-09 Composition and method for treating patients with hepatic disease

Publications (1)

Publication Number Publication Date
ATE209864T1 true ATE209864T1 (de) 2001-12-15

Family

ID=21843089

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94103163T ATE209864T1 (de) 1993-03-09 1994-03-03 Zusammensetzung zur behandlung von patienten mit lebererkrankungen

Country Status (10)

Country Link
US (1) US5571783A (de)
EP (1) EP0614616B1 (de)
JP (1) JPH0748270A (de)
AT (1) ATE209864T1 (de)
AU (1) AU5763094A (de)
CA (1) CA2116947A1 (de)
DE (1) DE69429297T2 (de)
DK (1) DK0614616T3 (de)
ES (1) ES2167338T3 (de)
PT (1) PT614616E (de)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9419345D0 (en) * 1994-09-26 1994-11-09 Sandoz Nutrition Ltd Organic compounds
US5589468A (en) * 1995-01-13 1996-12-31 Clintec Nutrition Co. Method for providing nutrition to elderly patients
CA2210499A1 (en) * 1995-02-23 1996-08-29 Novartis Nutrition Ag Amino acid compositions and use thereof in a clinical nutrition
GB9512100D0 (en) * 1995-06-14 1995-08-09 Sandoz Nutrition Ltd Improvements in or relating to organic compounds
US5656608B1 (en) * 1995-02-23 2000-09-26 Novartis Nutrition Ltd Amino acid compositions and methods of treatment using same
CA2173780A1 (en) * 1995-06-01 1996-12-02 Randy Grote Method for providing nutrition in a variety of compositional forms
US5728678A (en) * 1995-06-06 1998-03-17 Nestec Ltd. Method and composition for providing nutrition to a renal failure patient
JPH09194364A (ja) * 1996-01-22 1997-07-29 Snow Brand Milk Prod Co Ltd ビタミンａ吸収促進剤
IL126474A (en) * 1996-04-12 2001-03-19 Beth Israel Hospital Diabetic supplement bar
US5866555A (en) * 1997-03-12 1999-02-02 Beth Israel Deaconess Medical Center Diabetic supplement bar
US5817329A (en) * 1997-02-28 1998-10-06 Gardiner; Paul T. Nutritional supplement for increased muscle size and strength for body builders
IT1291126B1 (it) * 1997-04-01 1998-12-29 Sigma Tau Ind Farmaceuti Composizioni solide atte alla somministrazione orale comprendenti sali non igroscopici della l-carnitina e delle alcanoil l-carnitine
ES2132021B1 (es) * 1997-05-28 2000-02-16 Riera Simon Schwartz Formulas de aminoacidos para personas de la tercera edad y procedimiento para el calculo de las mismas.
FR2765481B1 (fr) * 1997-07-07 2000-12-08 Jacques Bogart Sa Complexe amino-lipidique vitamine
US20040022827A1 (en) * 1997-09-30 2004-02-05 Chugai Seiyaku Kabusiki Kaisha Remedy for hepatopathy
US6864242B2 (en) * 2001-03-05 2005-03-08 Stephen P. Ernest Enteral formulation
ATE369045T1 (de) * 2001-11-26 2007-08-15 Nestec Sa Lagerstabiles nahrungsmittelprodukt enthaltend molkenprotein, verfahren zu seiner herstellung und verwendung
US20030105104A1 (en) * 2001-11-27 2003-06-05 Burzynski Stanislaw R. Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy
EP1466602A4 (de) * 2001-12-25 2006-03-01 Ajinomoto Kk Organfibroseinhibitoren
EP2260845A3 (de) * 2002-06-21 2012-08-22 L'Oréal Verwendung von Polyphenolen zur Behandlung der Alopezie
EP1541141A1 (de) * 2002-08-30 2005-06-15 Ajinomoto Co., Inc. Therapeutisches mittel gegen lebererkrankungen
US20040219188A1 (en) * 2003-05-02 2004-11-04 Comer Gail M. Composition and methods for nutritional management of patients with hepatic disease
US7256202B2 (en) * 2003-12-31 2007-08-14 Halow George M Composition and method for treatment of hepatic encephalopathy
US20060089412A1 (en) * 2004-10-18 2006-04-27 Ajinomoto Co. Inc. Pharmaceutical composition for the treatment of non-alcoholic fatty liver disease
ES2448549T3 (es) * 2004-11-26 2014-03-14 Ucl Business Plc Composiciones que comprenden ornitina y fenilacetato o fenilbutirato para tratar encefalopatía hepática
JP2006241140A (ja) * 2005-02-01 2006-09-14 Otsuka Pharmaceut Factory Inc 肝疾患用栄養組成物
BRPI0619905A2 (pt) * 2005-12-15 2011-10-25 Nestec Sa composições e métodos para conservar função cerebral
CA2646672A1 (en) * 2006-03-23 2007-09-27 Nestec S.A. High-calorie nutritional supplement
US20090092657A1 (en) * 2007-10-09 2009-04-09 Douglas Burke Amino acid combinant omega oil aphrodisiac
RU2379065C1 (ru) * 2008-04-24 2010-01-20 Государственное учреждение научно-исследовательский институт общей реаниматологии Российской академии медицинских наук Способ зондового питания больных с черепно-мозговой травмой
WO2010005961A2 (en) 2008-07-07 2010-01-14 Pentech Health, Inc. Nutritive compositions and methods of using same
ES2652187T3 (es) 2009-04-03 2018-01-31 Ocera Therapeutics, Inc. Fenilacetato de l-ornitina y métodos para elaborar el mismo
EP2440200B8 (de) 2009-06-08 2014-10-15 UCL Business PLC Behandlung von pfortaderhochdruck mittels l-ornithin-phenylacetat
RU2500301C1 (ru) * 2009-12-18 2013-12-10 Стукли-Ван Кэмп, Инк. Белковый восстанавливающий напиток
GB2489163A (en) * 2010-01-04 2012-09-19 Pentec Health Inc Nutritive compositions and methods of using same
US9486003B2 (en) * 2010-06-28 2016-11-08 Nestec S.A. Hypocaloric, high protein nutritional compositions and methods of using same
KR101213825B1 (ko) 2010-07-16 2012-12-18 서울대학교산학협력단 세린을 유효성분으로 함유하는 지방간 질환의 예방 및 치료용 조성물
EP2625162B1 (de) 2010-10-06 2019-03-13 Ocera Therapeutics, Inc. Verfahren zur herstellung von l-ornithin-phenyl-acetat
US20210176999A1 (en) 2011-04-17 2021-06-17 Omega Foods, LLC Prepared foods having high efficacy omega-6/omega-3 balanced polyunsaturated fatty acids
WO2013133691A1 (en) * 2012-03-09 2013-09-12 N.V. Nutricia Liquid nutritional composition comprising free amino acids
KR102487376B1 (ko) 2014-11-24 2023-01-10 유씨엘 비즈니스 리미티드 암모니아-저감 치료를 이용한 간성상세포 활성화와 연관된 질병의 치료
JP6990170B2 (ja) 2015-08-18 2022-01-12 オセラ セラピューティクス， インコーポレイテッド Ｌ－オルニチンをフェニルアセテートおよびフェニルブチレートのうちの少なくとも１つと組み合わせて用いる筋肉喪失の治療および予防
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
CN110740988A (zh) 2017-05-11 2020-01-31 欧塞拉治疗有限公司 制备l-鸟氨酸苯乙酸盐的方法
SG11202001142VA (en) 2017-08-14 2020-03-30 Axcella Health Inc Amino acid compositions for the treatment of liver disease
US10596136B2 (en) 2018-06-20 2020-03-24 Axcella Health Inc. Compositions and methods for the treatment of fat infiltration in muscle

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3697287A (en) * 1969-01-28 1972-10-10 Morton Norwich Products Inc Amino acid food composition
US3698912A (en) * 1969-07-01 1972-10-17 Morton Norwich Products Inc Process for making nutrient composition
US3773930A (en) * 1971-03-23 1973-11-20 Johnson & Johnson Amino acid composition
IT987278B (it) * 1973-05-11 1975-02-20 Snam Progetti Procedimento per la preparazione di l carbamil ammino acidi e dei corrispondenti l amminoacidi
US3920838A (en) * 1973-09-04 1975-11-18 Flatt Jean Pierre Amino acid therapy
GB1511302A (en) * 1974-04-15 1978-05-17 Univ Johns Hopkins Pharmaceutical compositions comprising amino acid analogues
US4100293A (en) * 1974-04-15 1978-07-11 The Johns Hopkins University Treatment of hepatic disorders with therapeutic compositions comprising keto analogs of essential amino acids
US3950529A (en) * 1975-02-03 1976-04-13 Massachusetts General Hospital Amino acid formulations for patients with liver disease and method of using same
US4098910A (en) * 1975-02-19 1978-07-04 International Flavors & Fragrances Inc. Flavoring with certain 3-furyl alkyl disulfides
US4025650A (en) * 1975-11-24 1977-05-24 Control Drug, Inc. Method and composition for preventing nutritional deficiency
US4053589A (en) * 1975-11-24 1977-10-11 Control Drug Inc. Method of treating nutritional deficiency during cardiac cachexia, diabetes, hypoglycemia, gastroenterology, lipid, cell glycogen and keratin-related skin conditions and alcoholism
US4124448A (en) * 1976-04-09 1978-11-07 The Regents Of The University Of Minnesota Process for the large scale production of human growth hormone by serial secondary suspension culture
US4288546A (en) * 1976-04-09 1981-09-08 The Regents Of The University Of Minnesota Process for the large scale production of pituitary hormones by serial secondary suspension culture
US4082613A (en) * 1976-04-23 1978-04-04 The Regents Of The University Of Minnesota Process for the production of insulin by genetically transformed fungal cells
US4288542A (en) * 1976-04-30 1981-09-08 The Upjohn Company Radioenzymatic assay of catecholamines
GB1592791A (en) * 1977-01-07 1981-07-08 Radiochemical Centre Ltd Selenium- or tellurium-containing bile acids and derivatives thereof
DE2750159C3 (de) * 1977-11-09 1980-05-22 Lentia Gmbh, Chem. U. Pharm. Erzeugnisse - Industriebedarf, 8000 Muenchen Infusionslösung zur Behandlung von hepatischer Encephalopathie und ein Verfahren zu deren Herstellung
US4320146A (en) * 1978-03-17 1982-03-16 The Johns Hopkins University Treatment of hepatic and renal disorders with ornithine and arginine salts of branched chain keto acids
JPS5536457A (en) * 1978-09-08 1980-03-14 Ajinomoto Co Inc Amino acid infusion
JPS5564512A (en) * 1978-11-11 1980-05-15 Kanebo Ltd Cosmetic composition of oil-in-water emulsion
US4391909A (en) * 1979-03-28 1983-07-05 Damon Corporation Microcapsules containing viable tissue cells
US4352814A (en) * 1979-04-18 1982-10-05 The Johns Hopkins University Treatment of hepatic and renal disorders with mixed salts of essential or semi-essential amino acids and nitrogen-free analogs
US4254103A (en) * 1979-06-08 1981-03-03 Institul de Cercetari Chimicofarmaceutice Hepatoprotector Factor (HF) and method of treatment
US4216065A (en) * 1979-06-18 1980-08-05 University Of Delaware Bio-selective electrode probes using tissue slices
US4252822A (en) * 1979-12-26 1981-02-24 Children's Hospital Medical Center Method for treating phenylketonuria
USRE30753E (en) * 1980-01-07 1981-09-29 The Regents Of The University Of Minnesota Process for the large scale production of human growth hormone by serial secondary suspension culture
US4284647A (en) * 1980-03-31 1981-08-18 The Johns Hopkins University Process for waste nitrogen removal
JPS5729949A (en) * 1980-07-30 1982-02-18 Nippon Koutai Kenkyusho:Kk Determination of sugar branch related to cancer and diagnostic technique of cancer
JPS5852634B2 (ja) * 1980-12-05 1983-11-24 株式会社林原生物化学研究所 ウロキナ−ゼの製造法
US4529543A (en) * 1981-02-24 1985-07-16 Newport Pharmaceuticals International Hepatosin
US4898879A (en) * 1981-06-29 1990-02-06 Baxter International Inc. Nurtitional composition for management of hepatic failure
JPS58126767A (ja) * 1982-01-22 1983-07-28 Ajinomoto Co Inc 肝臓病患者用栄養組成物
US4612302A (en) * 1983-11-14 1986-09-16 Brigham And Women's Hospital Clinical use of somatostatin analogues
FR2556594B1 (fr) * 1983-12-20 1988-09-09 Synthelabo Solutions d'acides amines
CH658165A5 (fr) * 1984-01-04 1986-10-31 Nestle Sa Produit alimentaire efficace dans le traitement de la lepre.
US4703062A (en) * 1984-01-16 1987-10-27 Baxter Travenol Laboratories, Inc. Parenteral nutrition with medium and long chain triglycerides
US4704394A (en) * 1984-04-25 1987-11-03 Technology Unlimited, Inc. Treatment for hyperactivity
US4687782A (en) * 1984-12-10 1987-08-18 Nutri-Fuels Systems, Inc. Nutritional composition for enhancing skeletal muscle adaptation to exercise training
DE3521226A1 (de) * 1985-02-08 1986-08-14 Hoechst Ag, 6230 Frankfurt Gene fuer biologisch aktive proteine
JPH0667831B2 (ja) * 1986-01-13 1994-08-31 森永乳業株式会社 肝物質合成機能障害改善用のアミノ酸組成物
US4863898A (en) * 1986-02-06 1989-09-05 Albion International, Inc. Amino acid chelated compositions for delivery to specific biological tissue sites
US4920098A (en) * 1986-09-17 1990-04-24 Baxter International Inc. Nutritional support or therapy for individuals at risk or under treatment for atherosclerotic vascular, cardiovascular, and/or thrombotic diseases
US5053387A (en) * 1987-02-20 1991-10-01 Shriners Hospitals For Crippled Children Omega-3 fatty acids in traumatic injury treatment
US4780309A (en) * 1987-06-16 1988-10-25 Warner-Lambert Company Edible aerosol foam compositions and method of preparing same
CA1333471C (en) * 1988-04-29 1994-12-13 Gustavo Bounous Whey protein concentrate as food supplement
JPH02145170A (ja) * 1988-11-29 1990-06-04 Nippon Oil & Fats Co Ltd 液状蛋白補助食品
US5221668A (en) * 1992-02-26 1993-06-22 Abbott Laboratories Nutritional product for trauma and surgery patients

Also Published As

Publication number Publication date
CA2116947A1 (en) 1994-09-10
AU5763094A (en) 1994-09-15
US5571783A (en) 1996-11-05
EP0614616B1 (de) 2001-12-05
EP0614616A3 (de) 1995-07-26
DK0614616T3 (da) 2002-01-14
DE69429297T2 (de) 2002-10-24
DE69429297D1 (de) 2002-01-17
PT614616E (pt) 2002-04-29
JPH0748270A (ja) 1995-02-21
EP0614616A2 (de) 1994-09-14
ES2167338T3 (es) 2002-05-16

Similar Documents

Publication Publication Date Title
DE69429297D1 (de) Zusammensetzung zur Behandlung von Patienten mit Lebererkrankungen
DE69305105D1 (de) Zusammensetzungen zur oralen Nahrungsmittelaufnahme mit verbessertem Geschmack
DE69822832D1 (de) Therapeutische und lebensmittel-zusammensetzungen, welche essentielle fettsäuren und bioaktive disulfide enthalten
ATE215320T1 (de) Nahrungszusammensetzungen in verschiedenen formen
ATE323480T1 (de) Zusammensetzungen, enthaltend pinolensäure sowie deren verwendung zur gesundheitserhaltung
ATE96621T1 (de) Protein-, peptid- und aminosaeurenmischungen mit optimierter aminosaeurenzusammensetzung.
ATE81290T1 (de) Zusammensetzungen mit einem gehalt an mikroflora mit erhoehter adhaesion.
SE8505048L (sv) Nutritionsemulsion med syretransporterande egenskaper
ATE213499T1 (de) Peptidanaloge des menschlichen, basischen myelinproteins mit substitution an position 91 zur behandlung der multiplen sklerose
DK0598770T3 (da) Pyrazinderivater samt fremstilling og anvendelse deraf
ATE272321T1 (de) Modifizierte fettmischungen
ATE91392T1 (de) Formulierung zur behandlung der nierenkrankheiten.
AU652988B2 (en) Method for insuring adequate intracellular glutathione in tissue
DE69430416D1 (de) Zusammensetzungen aus Aminosäure zur Behandlung von Infektionen
WO1988003150A3 (en) N,n'-bis-amino acid-l-cystine-peptide-containing amino acid preparations for oral and parenteral administration
DE69330177D1 (de) Zusammensetzung und Verfahren zur Verminderung des Hypotensionsrisikos
DE69205562D1 (de) Dicarbonsäure-derivate von 6-12 kohlenstoffatomen sowie anwendung dieser derivate sowie der freien dicarbonsäuren zur herstellung von arzneimitteln zur enteralen und parenteralen ernährung.
DE58903919D1 (en) Propanolaminderivate.
NO894083D0 (no) Framsoeytiske blandinger for behandling av adrenoleukodystrophy.
DE69507026D1 (de) Naehrungsformell
ATE96150T1 (de) Thioester und dessen verwendung zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von ischaemie und von reperfusionsyndromen.
MX9605829A (es) Inhibicion de la union del h. influenzae a celulas humanas.
ATE31623T1 (de) Injizierbare zusammensetzungen von bbm-928a.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee